EpCAM inhibits differentiation of human liver progenitor cells into hepatocytes in vitro by activating Notch1 signaling
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 525 (1) , 238-243
Abstract
No abstract availableKeywords
Funding Information
- National Key R&D Program of China (2018YFA0108200)
This publication has 28 references indexed in Scilit:
- A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitroBiomedicine & Pharmacotherapy, 2019
- EpCAM and the biology of hepatic stem/progenitor cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2015
- Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and ReprogrammingCell Stem Cell, 2014
- The Emerging Role of EpCAM in Cancer and Stem Cell SignalingCancer Research, 2009
- EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell PhenotypeStem Cells, 2009
- Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor†Hepatology, 2007
- Origin and characterization of a human bipotent liver progenitor cell line☆Gastroenterology, 2004
- Frequent EpCam protein expression in human carcinomasHuman Pathology, 2004
- Infection of a human hepatoma cell line by hepatitis B virusProceedings of the National Academy of Sciences, 2002
- The biology of the 17–1A antigen (Ep-CAM)Journal of Molecular Medicine, 1999